Delirium in the elderly: biomarkers and outcomes

: A prospective cohort study in older adults with hip fracture

Baseline cerebrospinal fluid complement balance is associated with longitudinal memory decline in relation to plasma p‑tau181 levels in mild cognitive impairment

The role of complement in Alzheimer's disease (AD) remains unclear, particularly regarding tau pathology and memory decline.

Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis

Plasma and cerebrospinal fluid (CSF) protein biomarkers in amyotrophic lateral sclerosis (ALS) may provide insight into disease mechanisms and yield clinically useful biomarkers.

Complement system and glial activation biomarkers in cerebrospinal fluid: correlation with Alzheimer’s pathology

Evaluating the 8‐Year Association Between Cognition and Beta Amyloid in the Dallas Lifespan Brain Study Cohort

Mounting evidence suggests beta amyloid (Aβ) is not the sole initiating driver of cognitive decline in Alzheimer's disease (AD). This study explores whether there is an association between cognitive decline over eight years and Aβ.

Correction: Analysis of cognitive function trajectories and influencing factors in elderly patients with ischemic stroke: a prospective longitudinal study

[This corrects the article DOI: 10.3389/fnagi.2026.1733972.].